MMedication Read More LEQEMBI® (Lecanemab) Approved for the TreatmentSeptember 26, 2025 TOKYO and CAMBRIDGE, Mass., Sept. 24, 2025 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito,…